Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer

Natasha B. Leighl, Nina Karaseva, Kazuhiko Nakagawa, Byoung Chul Cho, Jhanelle E. Gray, Tina Hovey, Andrew Walding, Anna Rydén, Silvia Novello

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Nursing and Health Professions